At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02396 B&K CORP-B
Closed Easter Monday 04-02 14:39:45
7.400
-0.260
-3.39%
High7.680
Low7.400
Vol6.80K
Open7.660
D1 Closing7.660
Amplitude3.66%
Mkt Cap870.67M
Tradable Cap614.36M
Total Shares117.66M
T/O51.93K
T/O Rate0.01%
Tradable Shares83.02M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
B&K CORP-B (02396) sets 30 Mar 2026 board meeting to review FY2025 results and dividend proposal
B&K Corp Ltd is a China-based company principally engaged in the research and development of biopharmaceutical products. The Company committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The Company primarily focus on the discovery, development and commercialization of therapies for wound healing, currently platelet-derived growth factor (PDGF) drugs. The Company mainly operates its businesses in the domestic market.